Chemistry

 

Nadirov R.K.1, Dossymkhanova M.K.2

1Kazakh National University named after al-Farabi, Almaty, Kazakhstan

2Central Kazakhstan institute of technology and management, Balkhash, Kazakhstan

rash76@rambler.ru

 

ELECTROSYNTHESIS OF FLAVOPIRIDOL

 

Flavopiridol ((-)-2-(2-Chlorophenyl)-5,7-dihydroxy-8-[(3R,4S)-3-hydroxy-1-methyl-4-piperidinyl]-4H-1-benzopyran-4-one) (see Fig. below) is a synthetic flavon with antitumor activity [1-3]. Potent inhibitor of cyclin-dependent kinases  (CDKs). Induces apoptosis in certain tumor cells. Interacts with multidrug resistance protein 1 (MRP1). Soluble in chloroform; slightly soluble in water. For the first time synthesized at the end of past century.

Known processes of synthesis of flavopiridol are difficult and sequential. The present work has led to the development of a facile and environmentally friendly  electrochemical method for synthesis of flavopiridol on the base of chrysin (5,7-dihydroxyflavone) and N-methyl piperidine. All of reagents  were reagent grade materials   from Aldrich.

The first stage of the process of synthesis of flavopiridol is chlorination of chrysin. Electrolysis is performed in an electrolytic cell equipped a diaphragm to separate the cell into a cathode compartment and anode compartment. The cell is placed in a bath of ice water. The anode is a 5 cm2 plate of glassy carbon and the cathode is stainless stell. The anode compartment is filled with 200 ml of mixed solvent, 0.5g of KCl and 60 mg of chrysin. The cathode compartment is filled with   100 ml of mixed solvent and 0.3 g of KCl. Electrolysis were carried out with a constant potential (1.0 V versus Ag+/Ag).

Electrolysis of N-methyl piperidine is performed in other  divided cells at  room temperature in the mixed solvent in the presence of KOH. The anode compartment contains 10 ml of N-methyl piperidine and 50 ml of mixed solvent and 0.2 g of KOH. The working electrode (anode) was a glassy carbon plate (1 ×1.5 cm ). Electrolysis were carried out with a constant current density (25 mA/cm2). Electrolysis is stopped after passing through the cell 1.5 F per mole of N-methyl piperidine.

The anolyte  of electrolysis of N-methyl piperidine were added into the anode compartment of cell of electrolysis of chrysin when the current decreased by more than 70%. Electrolysis is stopped after passing through the cell 3 F per mole of chrysin.

At the end of electrolysis the solvent of anolyte  were vacuum distillated and the residuum were washed with aqueous NaHCO3 and water and purified with column chromatography (silica gel). After purification, the products were characterized by IR and 1H NMR. 

According to the IR and 1H NMR results we suggest that flavopiridol (yellow powder) were synthesized  (yield 3%).

We suggest that the first stage of the process of synthesis of flavopiridol is chlorination of chrysin; one of products of this stage is 2/-chlorchrysin.

Determination of the next stages will be thanks to prospected investigations  using electrochemical (voltammetry) and physicochemical methods. We suppose the creating favourable conditions for selective synthesis of 2/-chlorchrysin is necessary condition for increasing of desired product yields. It may be made by optimization of experiment by variation of next parameters: concentration of  substrate; concentration of  KCl; time of electrolysis; pH. The next stage of process is synthesis of flavopiridol on base of 2/-chlorchrysin and N-methyl piperidine.

References

1.                            Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK)2 and CDK4 in human breast carcinoma cells: B.A. Carlson, et al.; Cancer Res. 56, 2973 (1996)

2.                            Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional. p53: J.C. Byrd, et al.; Blood 92, 3804 (1998)

3.                            Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIPL: T.E. Fandy, et al.; Cancer Chemother. Pharmacol. 60, 313 (2007)